Progressive Care, Inc.
RXMD · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $50 | $41 | $39 | $39 |
| % Growth | 22.5% | 4.5% | -0.2% | – |
| Cost of Goods Sold | $35 | $31 | $29 | $30 |
| Gross Profit | $15 | $10 | $10 | $9 |
| % Margin | 30.5% | 23.9% | 26.2% | 23% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $12 | $11 | $10 |
| SG&A Expenses | $14 | $12 | $11 | $10 |
| Sales & Mktg Exp. | $5 | $0 | $0 | $0 |
| Other Operating Expenses | $29 | -$2 | $0 | $0 |
| Operating Expenses | $33 | $10 | $11 | $10 |
| Operating Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -0.2% | -1.2% | -2.7% | -2.6% |
| Other Income/Exp. Net | -$19 | -$3 | $1 | -$0 |
| Pre-Tax Income | -$19 | -$6 | $0 | -$1 |
| Tax Expense | -$5 | $0 | $0 | $0 |
| Net Income | -$15 | -$6 | -$1 | -$1 |
| % Margin | -29.5% | -14.5% | -3% | -3.7% |
| EPS | -2.36 | -2.03 | -0.45 | -0.63 |
| % Growth | -16.3% | -351.1% | 28.6% | – |
| EPS Diluted | -2.36 | -2.03 | -0.38 | -0.63 |
| Weighted Avg Shares Out | 6 | 3 | 3 | 2 |
| Weighted Avg Shares Out Dil | 6 | 3 | 3 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $2 |
| Depreciation & Amortization | $2 | $0 | $1 | $1 |
| EBITDA | $1 | -$2 | -$0 | -$0 |
| % Margin | 3% | -4.6% | -1.2% | -0.4% |